X4 Pharmaceuticals, Inc — Director's Dealing 2021

Jan 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2021-01-05

Reporting Person: Ragan Paula (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-05	Common Stock	S	2400	$7	Disposed	277723	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.